Toward a framework for psychedelic clinical trials in adolescents

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Psychedelics show therapeutic promise for adult mental health conditions.
• Mental health disorders often emerge during adolescence, a critical neurodevelopmental period.
• Regulatory agencies anticipate trials in younger populations post-adult approval.

Purpose of the Study:

• To provide a framework for designing and conducting psychedelic therapy clinical trials in adolescents.
• To ensure safety, ethical conduct, and scientific rigor in pediatric psychedelic research.
• To foster patient-centric dialogue among regulators and scientists.

Main Methods:

• Adapting established methodologies from adult psychedelic trials.
• Incorporating enhanced psychological support and supervision tailored for adolescents.
• Detailing specific safeguards and best practices for pediatric trial design.

Main Results:

• The paper presents key considerations for adolescent psychedelic trial design.
• It highlights the necessity of increased psychological support and rigorous oversight.
• It establishes a framework for safe and ethical pediatric psychedelic research.

Conclusions:

• Future psychedelic therapy trials in adolescents require specialized protocols.
• Adolescent-focused safeguards are crucial for ethical and scientific integrity.
• A patient-centric approach is vital for advancing psychedelic treatments in youth.